An oncolytic herpes simplex virus vector, G47∆, synergizes with paclitaxel in the treatment of breast cancer

By            

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2355-2361

Spandidos Publications

Access to resources Recommend Favorite

Pilot Study of Oncolytic Viral Therapy Using Mutant Herpes Simplex Virus (HF10) Against Recurrent Metastatic Breast Cancer

By Kimata Hideto   Imai Tsuneo   Kikumori Toyone   Teshigahara Osamu   Nagasaka Tetsuro   Goshima Fumi   Nishiyama Yukihiro   Nakao Akimasa  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1078-1084

Springer Publishing Company

Access to resources Recommend Favorite

The oncolytic herpes simplex virus vector G47∆ effectively targets breast cancer stem cells

By              

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1108-1114

Spandidos Publications

Access to resources Recommend Favorite

Angiogenesis Inhibition Using an Oncolytic Herpes Simplex Virus Expressing Endostatin in a Murine Lung Cancer Model

By Goodwin Jonathan M.   Schmitt Anthony D.   McGinn Christopher M.   Fuchs Bryan C.   Kuruppu Darshini   Tanabe Kenneth K.   Lanuti Michael  

Cancer Investigation, Vol. 30, Iss. 3, 2012-02 ,pp. : 243-250

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?

By Kanai Ryuichi   Wakimoto Hiroaki   Cheema Tooba   Rabkin Samuel D  

Future Oncology, Vol. 6, Iss. 4, 2010-04 ,pp. : 619-634

Future Medicine

Access to resources Recommend Favorite